Santarus Ulcerative Colitis Drug to Hit Shelves in March

Washington Drug Letter
A A
The FDA has approved Santarus’ daily extended-release drug Uceris to induce remission of mild to moderate active ulcerative colitis, a form of inflammatory bowel disease.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00